The Study That Shook the Industry
On July 6, 2026, JAMA published a secret shopper study from Yale School of Medicine that quantified what many suspected: getting a GLP-1 prescription online is remarkably easy, and the quality of medical oversight varies enormously between platforms. A Yale medical student created a patient profile — a 27-year-old male qualifying for a GLP-1 — and attempted to obtain prescriptions from 49 different websites selling branded or compounded semaglutide and tirzepatide.
The numbers were striking: 45 of 49 websites (91.8%) issued a prescription. Approximately 67% required no interaction with a clinician at all — the "evaluation" consisted entirely of a patient-reported questionnaire. Some platforms approved prescriptions within 5 minutes of the application, and 69.4% shipped medication within 24 hours.
What This Means for You Personally
The study doesn't mean telehealth GLP-1 prescribing is universally dangerous. It means the range of quality is enormous. Some platforms provide thorough medical evaluations with qualified prescribers who review your history, screen for contraindications, and maintain ongoing clinical relationships. Others are essentially vending machines with a prescriber's signature attached.
Your job as a patient is to distinguish between the two. The study gives you a framework for doing that: look for the specific quality markers that the weakest platforms lacked.
Embody
Top Pick — $400 CPA
From $249/mo
Injectable semaglutide only. Compounded — not FDA-approved.
Paid link Check Eligibility →The Quality Checklist Based on Yale's Findings
- Clinician interaction required — at minimum, asynchronous review with a mechanism to ask questions. Ideally, a synchronous video or phone consultation.
- Thyroid screening — the intake should ask about personal and family history of MTC and MEN 2.
- Eating disorder screening — the study found many platforms skipped this entirely.
- Identity and BMI verification — beyond self-reporting. Photos, video visits, or documentation.
- Follow-up protocol — a scheduled check-in after starting treatment, not just refill automation.
- Prescriber contact mechanism — you should be able to reach the person who prescribed your medication with questions. The study found 8.2% of platforms offered no mechanism for this.
Platforms That Got It Right
The study also found platforms that maintained appropriate clinical standards while still operating efficiently. These platforms typically required a medical history review, offered clinician communication channels, screened for safety-relevant conditions, and didn't approve prescriptions in minutes.
When evaluating a telehealth GLP-1 platform, ask: "How will I interact with my prescriber?" "What happens if I have a question after my prescription is written?" "Do you screen for thyroid conditions and eating disorders?" "How quickly does the average patient get approved?" If the answer to the last question is "minutes," consider whether the answers to the first three questions are satisfactory.
Wellorithm
Science-Forward
From $199/mo
Compounded — not FDA-approved.
Paid link Check Eligibility →Sesame Care
Brand-Name Marketplace
From $99/visit
FDA-approved brand-name medications only (Wegovy, Zepbound, Foundayo). Not compounded.
Paid link Check Eligibility →